Abstract
As procedure volumes continue to rise driven by favorable demographics, unit sales for reconstructive implants will increase appreciably from 2005 to 2009. Europe will grow at a compound annual growth rate of approximately 9% over the forecast period, reaching a value of over $2.4 billion by 2009.